Clinical trial
Optimal Tuberculosis Screening and Tuberculosis Preventive Therapy Delivery Strategies to Improve Maternal and Birth Outcomes Among Pregnant Women With HIV in Uganda: a Randomized Trial
NCT07278453 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimal Tuberculosis Screening and Tuberculosis Preventive Therapy Delivery Strategies to Improve Maternal and Birth Outcomes Among Pregnant Women With HIV in Uganda: a Randomized Trial
- Lead sponsor
- University of California, San Francisco
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- June 30, 2026
- Completion date
- June 30, 2031
- Enrollment
- 1,500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hiv, pregnant hiv positive women, tuberculosis (tb)